| |
IQVIA data scientists have created a framework, known as CASTER, to help you identify potential negative drug-drug interactions and account for them during the drug design process. Download the Insight Brief. 
|
|
| By Eric Sagonowsky,Fraiser Kansteiner Just two weeks after Biogen completed its buyout of Reata Pharmaceuticals, the combined company is trimming its staff. Reata staffers who worked in roles that are already covered at Biogen are losing their jobs. |
|
|
|
By James Waldron Outside of a global pandemic, it’s rare for a medicine to truly become a household name. But Novo Nordisk’s Wegovy is rapidly reaching that status, with the obesity drug accruing more front pages and celebrity endorsers every day. |
By Kevin Dunleavy People who use Novo Nordisk’s popular weight-loss drugs are taking on a small risk of developing severe stomach problems, according to research conducted by the University of British Columbia. The investigation indicates a link between Novo’s GLP-1 products and gastroparesis, pancreatitis and bowel obstruction. Still, the investigators emphasized that the risk was very small. |
By Gabrielle Masson You're not going to hear a private biotech trumpeting a down round as they announce a new batch of funding, but industry experts say the broader market trend has seeped into the sector. That's because a down round used to ring red-hot alarm bells. But as valuations change, investors say the meaning of a down round might too. |
|
Tuesday, October 17, 2023 | 12pm ET / 9am PT As real-world datasets have emerged over the past decade, a few tactics have become habits for pharma marketers. This set of shorthand practices has delivered impressive returns initially but is regressing in performance as it becomes a baseline for any brand. Join this Q+A session to learn how to revamp your HCP targeting strategy. Register now. 
|
|
By Angus Liu After years serving as a rumored target of Big Pharma M&A, Mirati Therapeutics has finally made its sale a reality. The buyer, Bristol Myers Squibb, will pay up to $5.8 billion for the KRAS drugmaker. |
By Annalee Armstrong,Max Bayer Eikon Therapeutics, a biotech that snatched several big-name executives from Merck & Co. and raked in some of the largest financing rounds in recent memory, has cut staff in an effort to “become more efficient.” |
By Helen Floersh The lab of Nobel laureate Jennifer Doudna showed that CRISPR can lead to a phenomenon known as chromosome loss in T cells, but that preventing it lies in the order of gene editing operations. |
By Andrea Park This holiday season, the hottest electronic on sale at Best Buy just might be a continuous glucose monitor. |
By Kevin Dunleavy Flush with business during the COVID pandemic, the CDMO industry is struggling to adjust in the aftermath. Case in point is EuroAPI, which has slashed its projected revenue growth in 2023 from a range of 7% to 8% to a new window of 3% to 5%. The Sanofi spinoff also dropped its earnings estimate for the year. |
By Ben Adams AbbVie has once again taken the lead as the top spender on TV drug advertisements, but, among the top 10 pharmaceutical companies, it appears that all of them are increasing their advertising budgets, reversing the decline in total ad spending observed in the past few months. |
Fierce podcasts Don’t miss an episode |
| In this week's episode of "Podnosis," we explore how video game training can captivate users' minds while also expediting the adoption of new skills and treatments in medicine. |
|
|---|
|
|
|
Wednesday, October 18, 2023 | 11am ET / 8am PT Join industry experts for an exciting glimpse into the future of pharmaceutical innovation! Gain a comprehensive understanding of the latest strategies in organofluorine-based drug synthesis and learn key insights for staying ahead of the curve in this rapidly evolving landscape. Register now. 
|
|
eBook Learn how to get better results from suboptimal biospecimens for NGS and protein analysis. Sponsored by: Covaris |
Whitepaper Learn more about targeted personas for HCP marketing. Sponsored by: M3 |
eBook Learn how single-cell sequencing speeds up drug development and delivers valuable biological insights. Sponsored by: Single Cell Discoveries |
Webinar Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. Watch now to learn how cloud implementation fosters accessibility and collaboration, revolutionizing research across locations and companies. Sponsored by: Revvity Signals |
Whitepaper Learn how to help patients with chronic diseases access tailored condition and treatment insights in an environment where they are often inundated with one-size-fits-all messaging that doesn’t align with their individual healthcare journey. Sponsored by: Phreesia Life Sciences |
Research Daiichi Sankyo wanted to create a “single source of truth, the very first place you should go” for content access and rights information. How did they replace five tools with just one? Sponsored by: CCC |
Whitepaper From uncertainty to opportunity – Use cases for life sciences organizations to tap into the power of the metaverse and generative AI Sponsored by: Cognizant |
Whitepaper Economic and regulatory factors are making biopharma supply chains more complex in the EU. This paper explores strategies that biopharma companies can use to better manage complexity, cost, and risk. Presented by: AIM, the supply chain leader for life science entrants and midsize life science companies |
Whitepaper From Assay Development Through Large Molecule Development. Streamline your R&D workflows and gain valuable insights with our Biology Solutions Brochure. Download now to discover how to control your laboratory workflows across various assay techniques, modalities, and data types. Sponsored by: Revvity Signals |
Whitepaper Read this paper to learn how pharmaceutical and medical device manufacturers can improve their tender and deal management, as well as how to choose a global management platform and the best practices for implementing it. Sponsored by: Cognizant |
eBook Emulate in vivo biology with next-generation in vitro technology. Sponsored by: Emulate |
Whitepaper Discover five creative and innovative ways to reimagine your legacy biopharma campus and unlock value. Sponsored by: JLL |
Whitepaper Learn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
Whitepaper Learn how pharma marketers and other players in the industry can ease the way for consumers, ultimately improving health outcomes and boosting adherence in five simple steps. Sponsored by: Healthline Media |
| Edison Ballroom, New York City |
|
|
| |
|
